Biktarvy 50 mg/200 mg/25 mg film-coated tablets, Dovato 50 mg/300 mg film-coated tablets clinical trials

DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial

This study compares two common HIV treatments, Biktarvy and Dovato, to see if they are equally good at keeping the virus under control. Researchers want to find out if Dovato is as effective as Biktarvy in maintaining a very low amount of HIV in the blood.